Dystrophic Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Dystrophic Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Evaluation of D-Fi for the Treatment of Wounds Due to DEB [Phase 3]
This entry reports that Castle Creek Biosciences' Phase 3 trial evaluating D-Fi for treating wounds in Dystrophic Epidermolysis Bullosa is a…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa [Phase 3]
Phase 3 study evaluating KB803 versus matched placebo in Dystrophic Epidermolysis Bullosa is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study [Phase 2]
This is a Phase 2 clinical trial update for TCP-25 Gel in patients with epidermolysis bullosa, including dystrophic and junctional forms. Th…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa [Phase 1]
Phase 1 pilot study update for ELK-003 Eye Drops to treat ocular manifestations of epidermolysis bullosa, currently active/not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa [Phase 3]
Phase 3 clinical trial in Japanese patients with epidermolysis bullosa to evaluate the safety and efficacy of Oleogel-S10. Recruitment is on…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Ev.FV for wound healing in patients with dystrophic epidermolysis bullosa is currently recruiting.
-
EMA approval · 2025-06-30EMA Authorised: Vyjuvek (Beremagene geperpavec) — Krystal Biotech Netherlands B.V.
The European Medicines Agency has authorised Vyjuvek (beremagene geperpavec) for dystrophic epidermolysis bullosa in the EU, with orphan med…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: MSC EVs in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating mesenchymal stem cell-derived extracellular vesicles (MSC EVs) for dystrophic epidermolysis bull…
-
CLINICAL_TRIALS research · 2025-06-09Clinical Trial Update: Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) [Phase 1, Phase 2]
A clinical trial update evaluating efgartigimod alfa (Vyvgart) to treat bullous diseases by targeting collagen VII antibodies in Epidermolys…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)
This clinical trial update reports the completion of a study evaluating gynecological follow-up in patients with dystrophic epidermolysis bu…
-
EMA approval · 2025-02-28First topical gene therapy treatment for dystrophic epidermolysis bullosa
The European Medicines Agency approved Vyjuvek as the first topical gene therapy for dystrophic epidermolysis bullosa, an ultra-rare genetic…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa [Phase 3]
Phase 3 long-term treatment study of B-VEC for dystrophic epidermolysis bullosa has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]
Clinical trial evaluating safety of ALLO-ASC-DFU in subjects with Dystrophic Epidermolysis Bullosa has completed Phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating PTW-002 in patients with dominant or recessive dystrophic epidermolysis bullosa caused by COL7A1 ex…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of B-VEC for treating Dystrophic Epidermolysis Bullosa has completed with result…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients [Phase 1, Phase 2]
Phase I/II study of KB103 (Topical HSV1-COL7) in patients with Dystrophic Epidermolysis Bullosa has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB) [Phase 1]
Phase 1 pharmacokinetic study evaluating diacerein and rhein after maximum use in patients with epidermolysis bullosa, completed with result…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa [Phase 2]
A Phase 2 trial evaluated the efficacy of granulocyte colony-stimulating factor (G-CSF) in patients with dystrophic epidermolysis bullosa; r…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care [NA]
A completed clinical trial compared Helicoll collagen dressings with standard of care for treating wounds in patients with epidermolysis bul…
-
CLINICAL_TRIALS withdrawal · 2015-09-30Clinical Trial Update: Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB [NA]
This clinical trial evaluating photodynamic therapy for epidermal dysplasia in hereditary Dystrophic Epidermolysis Bullosa has been withdraw…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Clinical trial NCT00533572 evaluating a potential gene transfer approach for dystrophic epidermolysis bullosa has been terminated; no result…
-
CLINICAL_TRIALS withdrawal · 2013-05-21Clinical Trial Update: Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
The prospective, longitudinal natural history study in dystrophic epidermolysis bullosa has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-16Clinical Trial Update: A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa [Phase 2]
A Phase 2 pilot trial of HP802-247 for Dystrophic Epidermolysis Bullosa has been withdrawn.